Lister Troy 4
4 · Verve Therapeutics, Inc. · Filed Jun 25, 2024
Insider Transaction Report
Form 4
Lister Troy
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2024-06-21+32,000→ 32,000 totalExercise: $5.29Exp: 2034-06-20→ Common Stock (32,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 21, 2024. 25% of the shares underlying the option will vest on June 21, 2025, and the remainder are scheduled to vest in equal monthly installments thereafter until June 21, 2028.